The director buys post-strong earnings are a modest incremental positive, but the dollar amount is too small to drive institutional sentiment. Monitor for any c-suite open-market purchases to confirm director conviction. The stock remains 39% analyst-bullish with consensus hold — no immediate catalyst beyond earnings guidance.
Price Chart
Executive Summary
Two Pfizer directors (Blaylock and Buckley) made open-market purchases totaling ~$1.96M on the same day the company's SVP & Controller sold $83K. The director buys follow Pfizer's Q2 2026 earnings beat (reported Aug 4) where adjusted EPS of $0.77 beat consensus by 12.9% and revenue of $15.0B beat by 4.5%, alongside raised full-year guidance. The insider purchases suggest directors see value at the current ~$25.50/share level post-earnings, though the $1.96M total is tiny (0.0013% of Pfizer's $149B market cap) and the controller's small sale appears liquidity-driven.
Key Financial Metrics
Key Facts
- Two directors purchased 76.9K shares total for ~$1.96M on Aug 5, one day after Pfizer reported Q2 2026 earnings beat
- SVP & Controller Damico sold 3.3K shares for $83K on the same day (liquidity-sized, 0.00006% of market cap)
- Total insider buying of $1.96M is 0.0013% of Pfizer's $149.3B market cap — economically trivial
- Q2 2026 adjusted EPS of $0.77 beat consensus of $0.68 by 12.9%; revenue $15.0B beat $14.4B by 4.5%
- Full-year 2026 revenue guidance raised by $500M midpoint to $60.5-$62.5B; adj EPS guidance $2.80-$3.00 reaffirmed
Financial Impact
$1.96M in director open-market purchases, 0.0013% of $149.3B market cap
Risk Factors
- Insider buying at 0.0013% of market cap is too small to move the stock
- Historical PFE reports show -3.23% avg T+20 return across 9 prior calls (13% win rate)
- GAAP net loss of $0.04 per share in Q2 due to $4.3B non-cash impairments tempers headline bullishness
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PFE-1786083420400 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Court Ruling | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Buy | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 5, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 4, 2026 8w ago | 8-K | $25.41 $28.55 | ▲ +12.36% | ▲ +13.60% | $27.55 (+8.40%) |
Jul 31, 2026 9w ago | Court Ruling | $25.01 $27.96 | ▼ −11.80% | ▼ −8.81% | $27.55 (−10.14%) |
Jul 24, 2026 10w ago | Court Ruling | $24.54 $28.07 | ▲ +14.38% | ▲ +10.76% | $27.55 (+12.25%) |
Jul 6, 2026 12w ago | ANALYST-DOWNGRADE | $23.72 $25.01 | ▼ −5.44% | ▼ −6.00% | $27.55 (−16.13%) |
Jun 18, 2026 15w ago | 8-K | $25.21 $25.14 | ▼ −0.28% | ▼ −0.81% | $27.55 (+9.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access